Literature DB >> 30459476

New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Anushka Dongre1, Robert A Weinberg2,3,4.   

Abstract

Epithelial-mesenchymal transition (EMT) is a cellular programme that is known to be crucial for embryogenesis, wound healing and malignant progression. During EMT, cell-cell and cell-extracellular matrix interactions are remodelled, which leads to the detachment of epithelial cells from each other and the underlying basement membrane, and a new transcriptional programme is activated to promote the mesenchymal fate. In the context of neoplasias, EMT confers on cancer cells increased tumour-initiating and metastatic potential and a greater resistance to elimination by several therapeutic regimens. In this Review, we discuss recent findings on the mechanisms and roles of EMT in normal and neoplastic tissues, and the cell-intrinsic signals that sustain expression of this programme. We also highlight how EMT gives rise to a variety of intermediate cell states between the epithelial and the mesenchymal state, which could function as cancer stem cells. In addition, we describe the contributions of the tumour microenvironment in inducing EMT and the effects of EMT on the immunobiology of carcinomas.

Entities:  

Mesh:

Year:  2019        PMID: 30459476     DOI: 10.1038/s41580-018-0080-4

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  210 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  The epigenetics of epithelial-mesenchymal plasticity in cancer.

Authors:  Wai Leong Tam; Robert A Weinberg
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

3.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.

Authors:  Angela M Krebs; Julia Mitschke; María Lasierra Losada; Otto Schmalhofer; Melanie Boerries; Hauke Busch; Martin Boettcher; Dimitrios Mougiakakos; Wilfried Reichardt; Peter Bronsert; Valerie G Brunton; Christian Pilarsky; Thomas H Winkler; Simone Brabletz; Marc P Stemmler; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2017-04-17       Impact factor: 28.824

Review 4.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

5.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 6.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

7.  Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives.

Authors:  M Angela Nieto
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

8.  EMT and dissemination precede pancreatic tumor formation.

Authors:  Andrew D Rhim; Emily T Mirek; Nicole M Aiello; Anirban Maitra; Jennifer M Bailey; Florencia McAllister; Maximilian Reichert; Gregory L Beatty; Anil K Rustgi; Robert H Vonderheide; Steven D Leach; Ben Z Stanger
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

9.  Generation of breast cancer stem cells through epithelial-mesenchymal transition.

Authors:  Anne-Pierre Morel; Marjory Lièvre; Clémence Thomas; George Hinkal; Stéphane Ansieau; Alain Puisieux
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.

Authors:  Xin Ye; Wai Leong Tam; Tsukasa Shibue; Yasemin Kaygusuz; Ferenc Reinhardt; Elinor Ng Eaton; Robert A Weinberg
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

View more
  794 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 3.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

4.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

5.  ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Authors:  Wang Zeng; Shuchen Gu; Yi Yu; Yili Feng; Mu Xiao; Xin-Hua Feng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

6.  Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.

Authors:  Sijia Liu; Román González-Prieto; Mengdi Zhang; Paul P Geurink; Raymond Kooij; Prasanna Vasudevan Iyengar; Maarten van Dinther; Erik Bos; Xiaobing Zhang; Sylvia E Le Dévédec; Bob van de Water; Roman I Koning; Hong-Jian Zhu; Wilma E Mesker; Alfred C O Vertegaal; Huib Ovaa; Long Zhang; John W M Martens; Peter Ten Dijke
Journal:  Clin Cancer Res       Date:  2019-12-19       Impact factor: 12.531

Review 7.  The Chemistry and Biology of Ferroptosis.

Authors:  Brent R Stockwell; Xuejun Jiang
Journal:  Cell Chem Biol       Date:  2020-04-16       Impact factor: 8.116

8.  Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.

Authors:  Sarama Saha; Seema Parte; Partha Roy; Sham S Kakar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.

Authors:  Anand Vasudevan; Prasamit S Baruah; Joan C Smith; Zihua Wang; Nicole M Sayles; Peter Andrews; Jude Kendall; Justin Leu; Narendra Kumar Chunduri; Dan Levy; Michael Wigler; Zuzana Storchová; Jason M Sheltzer
Journal:  Dev Cell       Date:  2020-02-24       Impact factor: 12.270

10.  Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment.

Authors:  Lydia Livas; Sumati Hasani; Natasha Kyprianou
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.